HIV Prevention Program

2

Review clinical trials related to HIV Prevention Program. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP

The purpose of this project is to test a culturally-tailored, community-delivered long-acting injectable PrEP (lenacapavir) program for Latine gay and bisexual men (GBM) and transgender women (TGW). The objective is to evaluate whether this intervention demonstrates greater persistence on lenacapavir for Latine GBM and TGW compared with what has been observed historically at the Duke PrEP Clinic.

Participants needed: 100
Trial details
Phase: Phase 4Age: 18+Biological sex: MaleType: InterventionalSponsor: Duke UniversityUpdated: Feb 2, 2026Locations: 1
Eligibility criteria

Participants must be assigned male sex at birth. [+6]

Individuals living with HIV. [+4]

Status: Not yet recruiting

Academic Detailing to Optimize PrEP Implementation in Pediatric Primary Care Settings: ADOPT-PrEP

In this study, 50 pediatricians will participate in academic detailing, an evidence-based, 1-on-1 outreach education technique intended to promote clinician behavior change through brief, highly interactive, and individualized dialogues with trained educators, or "detailers". The goals of this study are to learn about whether this is a practical and acceptable technique, and whether it changes how pediatricians prescribe pre-exposure prophylaxis (PrEP) to adolescents and young adults (AYA) and how patients take it.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Boston Children's HospitalUpdated: Jan 26, 2026Locations: 1
Eligibility criteria

Primary care provider at one of our 3 study sites (Boston Children's Hospital Ad...

None